Abstract
Purpose: To study daily spinal cord and parotid gland dose variation for nasopharyngeal cancer patients undergoing helical tomotherapy treatments, as a result of patient weight loss during the course of treatments.Method and Materials: Five nasopharygeal cancer patients who received helical tomotherapy treatments were selected. At the end of the treatments, patients lost an average weight of 6.3 kg, or 8.4% relative to the weight at the beginning of the treatments. Daily megavoltage CT (MVCT) scans were performed prior to each treatment fraction, and MVCT images were registered with planning CTimages for patient setup corrections. Contours for spinal cord and parotid glands were drawn on MVCT images throughout the treatment course. Based on daily MVCT images, actual dose delivered to the critical structures were calculated using the Planned Adaptive application in the helical tomotherapy treatment planning system. The maximum dose to the spinal cord and the median doses to the parotid glands were analyzed. Results: The maximum dose to the spinal cord, after setup corrections, did not show significant variation as a result of patient weight loss. However, the median doses to the parotid glands showed significant increase due to facial tissue shrinkage during treatments. The average median dose to the parotid glands for the five patients were 83 cGy for the first treatment fraction, and it was 143 cGy per fraction for the last fraction. The average parotid gland volume decreased from 20.5 cc to 13.2 cc during treatments.Conclusion: Daily patient setup corrections based on MVCT image registrations prevented significant dose variation to the spinal cord due to setup uncertainty. During the course of radiotherapy, as a result of body weight loss, the parotid glands typically receive significantly higher dose compared to the dose dictated in the treatment plan.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.